1tvh: Difference between revisions

Revision as of 09:59, 17 February 2009

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1tvh.png

Template:STRUCTURE 1tvh

Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2

Template:ABSTRACT PUBMED 15814707

DiseaseDisease

Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]

About this StructureAbout this Structure

1TVH is a 6 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

^{[xtra 1]}

↑ Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J Immunol. 2005 Apr 15;174(8):4812-20. PMID:15814707

Page seeded by OCA on Tue Feb 17 08:59:11 2009

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

[1] Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J Immunol. 2005 Apr 15;174(8):4812-20. PMID:15814707

[xtra 1]

@@ Line 23: / Line 23: @@
 ==About this Structure==
-TVH is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TVH OCA].
+TVH is a 6 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TVH OCA].
 ==Reference==
-Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design., Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM, J Immunol. 2005 Apr 15;174(8):4812-20. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15814707 15814707]
+<ref group="xtra">PMID:15814707</ref><references group="xtra"/>
 [[Category: Homo sapiens]]
-[[Category: Protein complex]]
 [[Category: Baker, B M.]]
 [[Category: Borbulevych, O Y.]]
@@ Line 37: / Line 36: @@
 [[Category: X-ray]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 12:26:36 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 08:59:11 2009''

1tvh: Difference between revisions

Revision as of 09:59, 17 February 2009

Contents

Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2

DiseaseDisease

About this StructureAbout this Structure

ReferenceReference

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Navigation menu

1tvh: Difference between revisions

Revision as of 09:59, 17 February 2009

Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2

DiseaseDisease

About this StructureAbout this Structure

ReferenceReference

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Navigation menu

Search